GlassScriptPhysician profile
David Kovacevic
NPI 1841463122
$35,144.38
in general payments reported to CMS, 2019-2025
26 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,890 · 2020: $122 · 2021: $31.79 · 2022: $3,255 · 2023: $17K · 2024: $12K · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $5,928 · Food and Beverage: $5,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,000.00 |
| Travel and Lodging | $5,927.58 |
| Food and Beverage | $5,918.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $22,118.55 | 2023-2024 | Biobrace 23mm |
| Seapearl East, INC | $2,646.27 | 2022-2024 | |
| Depuy Synthes Sales INC. | $2,214.67 | 2019-2025 | Milagro, Healix Knotless Peek, Rigidloop |
| Ossio INC | $2,120.19 | 2024 | |
| Gotham Surgical Solutions & Devices, INC. | $1,859.72 | 2019 | |
| Geistlich Pharma, North America, INC. | $1,011.48 | 2024 | Geistlich Bio-Gide |
| Stryker Corporation | $643.12 | 2019-2023 | Gamma |
| Anika Therapeutics, INC. | $352.59 | 2023-2024 | Integrity, Revomotion |
| Zimmer Biomet Holdings, INC. | $347.63 | 2019-2020 | |
| Miach Orthopaedics, INC. | $322.00 | 2023-2024 | |
| Kerecis Limited | $288.30 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Nevro Corp. | $270.27 | 2022-2023 | Senza |
| Biorez, INC. | $227.25 | 2022 | |
| Medical Device Business Services, INC. | $150.30 | 2023 | Fms |
| Davol INC. | $134.66 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $94.43 | 2019 | |
| Integra Lifesciences Corporation | $72.73 | 2019 | |
| Catalyst Orthoscience | $63.30 | 2019 | |
| Shoulder Innovations, INC. | $47.56 | 2019 | |
| Vericel Corporation | $44.05 | 2025 | Maci |
| Horizon Therapeutics Plc | $31.79 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.12 | 2025 | |
| Fidia Pharma USA INC. | $18.00 | 2022 | |
| Smith+Nephew, INC. | $17.04 | 2019 | |
| Avanos Medical | $15.57 | 2022 | |
| Synergy Orthopedics, LLC | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kovacevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.